Chemically induced pluripotent stem cell therapy - DNAmicroarray
Alternative Names: CiPSC; CiPSC - Blood cells; CiPSC - Cardiovascular; CiPSC - NeuronalLatest Information Update: 14 Sep 2023
At a glance
- Originator DNAmicroarray
- Class Cardiovascular therapies; Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Blood dyscrasias; Cardiovascular disorders; Neurological disorders
Highest Development Phases
- Discontinued Blood dyscrasias; Cardiovascular disorders; Neurological disorders
Most Recent Events
- 14 Sep 2023 Discontinued - Preclinical for Blood dyscrasias in USA (Parenteral)
- 14 Sep 2023 Discontinued - Preclinical for Cardiovascular disorders in USA (Parenteral)
- 14 Sep 2023 Discontinued - Preclinical for Neurological disorders in USA (Parenteral)